The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
The FDA perspective on the development of stereoisomers
Abstract
The current regulatory position of the Food and Drug Administration is discussed with regard to the approval of racemates and pure stereoisomers. Circumstances in which stereochemically sensitive analytical methods are necessay to ensure the safety and efficacy of a drug are described. Regulatory guidelines are interpreted for applications for the approval of a pure enantiomer in which the racemate is marketed, for the approval of eitehr a racemate or a pure enantiomer in which neither is marketed, and for clinical investigations to compare the safety and efficacy of a racemate and its enantiomers. Examples of te basis for such regulation are drawn from historical situations (thalidomide, benoxaprofen) as well as currently marketed drugs (arylproionic acids, disopyramide, indacrinone).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specification of Molecular Chirality
Cahn, R. S., Ingold, C., & Prelog, V. (1966) · Angewandte Chemie International Edition in English · doi:10.1002/anie.196603851 · Cited by 1,877
Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
Ari�ns, E. J. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00541922 · Cited by 609
Hutt, A. J., & Caldwell, J. (1983) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1983.tb02874.x · Cited by 394
Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview
Drayer, D. E. (1986) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1986.150 · Cited by 314
Stereochemistry: A source of problems in medicinal chemistry
Ariëns, E. J. (1986) · Medicinal Research Reviews · doi:10.1002/med.2610060404 · Cited by 202
Toxicity and Teratogenicity of Optical Isomers of Thalidomide
FABRO, S., SMITH, R. L., & WILLIAMS, R. T. (1967) · Nature · doi:10.1038/215296a0 · Cited by 200
Simonyi, M. (1984) · Medicinal Research Reviews · doi:10.1002/med.2610040304 · Cited by 134
X-ray crystallography and drug action
Testa, B. (1985) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(85)90017-3 · Cited by 89
Stereospecific inversion of (R)-(−)-benoxaprofen in rat and man
Simmonds, R. G., Woodage, T. J., Duff, S. M., & Green, J. N. (1980) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189461 · Cited by 77
Effects of Non-Narcotic Analgesics on the Liver
Prescott, L. F. (1986) · Drugs · doi:10.2165/00003495-198600324-00010 · Cited by 68
Cited by
Broadening the Scope of Biocatalysis in Sustainable Organic Synthesis
Sheldon, R. A., & Brady, D. (2019) · ChemSusChem · doi:10.1002/cssc.201900351 · Cited by 306
Contextual Emergence in the Description of Properties
Bishop, R. C., & Atmanspacher, H. (2006) · Foundations of Physics · doi:10.1007/s10701-006-9082-8 · Cited by 183
Chirality in adsorption on solid surfaces
Zaera, F. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00367f · Cited by 172
Metadata
- Authors
- De Camp, W. H.
- Venue
- Chirality
- Publisher
- Wiley
- Published
- 1989-01
- Volume
- 1
- Issue
- 1
- Pages
- 2-6
- ISSN
- 0899-0042 (ISSN-L)
- 1520-636X
- OpenAlex
- W2074243254
- Cited by
- 285
- References
- 12
- FWCI
- 23.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.